🔎 Trials Near Me

Akèy › Kansè san › Ohio › Cleveland

Etid klinik pou Kansè san nan Cleveland, OH

6 etid pou Kansè san ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1
  • UH Seidman Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • University Hospitals Case Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Ap rekriteFaz 1/2
  • University Hospitals Cleveland, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2025 · NCT06119685

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Rainbow Babies, Cleveland
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Kansè san nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.